Vendor Intelligence Report: Tydes

Executive summary

Tydes is not a one-note quality story. Across 41 Finnrick lab tests, Tydes has 33 pass / 8 fail, an overall pass rate of 80%. Tirzepatide and retatrutide are the stronger current signals, with semaglutide close behind; BPC-157 is the line that should stop a cautious buyer from generalizing from the GLP-1 results. The full report shows how ratings move under stricter purity and fill grading.

The corporate trail is more revealing than the storefront address. Tydes presents a Charlotte, North Carolina posture, but a peptide release form, Florida filings, and a misspelled research-lab entity point back to a Sarasota-centered Schindelbeck cluster. A buyer searching only North Carolina would miss the operating trail reconstructed from filings, waiver language, and archived captures.

Tydes publishes third-party lab materials, including Janoshik identity/purity COAs and a TrustPointe endotoxin COA, which is a real trust signal for the batches covered. The weaker side is the manufacturing story: Made in USA and triple-testing claims appear without a named facility, manufacturer, cGMP certificate holder, or fill-finish site. A leftover skincare-template paragraph on the About page is not a product defect, but it does lower confidence in unverified marketing language.

Community mentions lean positive on shipping, packaging, single-vial availability, and service, but the promotion environment is not clean. The sweep found a peptide-themed X account using a personal Tydes discount code without visible disclosure, plus coupon pages carrying referral-style placements. The report also separates Tydes from a similarly named Canadian vendor while showing why channel authentication still matters.

Inside the full report:

• Appendix A with per-product pass/fail rates and methodology-divergence charts for all 7 tested products
• Florida corporate filings, seller-waiver evidence, and archived address changes connecting the storefront to the operating entities
• Manufacturing-claim verification, including Janoshik and TrustPointe COA analysis
• Site-content hygiene exhibits, including the skincare-template copy error on the About page
• Affiliate and coupon-code sweep with disclosure classifications for X, SEO coupon pages, and forum mentions
• Buyer-risk matrix covering BPC-157 quality, manufacturing opacity, corporate transparency, affiliate promotion, and brand-confusion exposure

Risk assessment

• BPC-157 quality risk — high: Finnrick's Tydes record is product-dispersed: BPC-157 is fail-heavy at 5 tests, 2 pass / 3 fail, with a 45.76% rating, unlike the stronger tested GLP-1/GIP products.
• Unverifiable manufacturing-claim risk — medium: Tydes claims Made in USA production and triple testing, but records reviewed identify no manufacturing facility or partner; operator history supports only a reseller/packer or contract-manufacturer inference.
• Corporate-transparency risk — medium: The public brand lists NC virtual mailbox addresses while linked Florida records use holding-company members and later-formed operating LLCs, making ownership harder for ordinary buyers to verify.
• Affiliate-promotion risk — medium: One third-party X promoter used personal 15% code REFROWANHOOPE without disclosure, and coupon/affiliate pages list Tydes referral links/codes with no or unclear disclosure.
• Brand-confusion / anti-counterfeit risk — medium: Community records distinguish Tydes from similarly named CanTydes, but materials reviewed did not show an official reseller/copycat-warning or anti-counterfeit verification page beyond COA links.